7th Annual USC Multi-Disciplinary Breast Cancer Symposium
New Data Show Pertuzumab + Trastuzumab + Chemo Continue Yielding Clinical Benefit / Adjuvant T-DM1 Benefit in HER2+ Early BC
Login to view comments.
Click here to Login
Videos